Zydus Life is buy for TP of ₹1439 (30% upside from CMP)

Discussion in 'Latest Brokerage Stock Buy-Sell Reports' started by Vidhi Khanna, Aug 27, 2024.

  1. Vidhi Khanna

    Vidhi Khanna Active Member Staff Member

    Joined:
    Mar 19, 2015
    Messages:
    757
    Likes Received:
    55
    Zydus Life is out of favour due to its acquisition of 50% stake in Sterling Biotech. Some experts say this is a buying opportunity given the strong fundamentals of Co. KR Choksey has recommended buy for TP of ₹1439 (30% upside from CMP). In any case, short-term bounce is likely

    [​IMG]

    [​IMG]
     
Loading...